The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Linkage of gut microbiome with cognition in hepatic encephalopathy
Open accessAbstract
Hepatic encephalopathy (HE) has been related to gut bacteria and inflammation in the setting of intestinal barrier dysfunction. We aimed to link the gut microbiome with cognition and inflammation in HE using a systems biology approach. Multitag pyrosequencing (MTPS) was performed on stool of cirrhotics and age-matched controls. Cirrhotics with/without HE underwent cognitive testing, inflammatory cytokines, and endotoxin analysis. Patients with HE were compared with those without HE using a correlation-network analysis. A select group of patients with HE (n = 7) on lactulose underwent stool MTPS before and after lactulose withdrawal over 14 days. Twenty-five patients [17 HE (all on lactulose, 6 also on rifaximin) and 8 without HE, age 56 ± 6 yr, model for end-stage liver disease score 16 ± 6] and ten controls were included. Fecal microbiota in cirrhotics were significantly different (higher Enterobacteriaceae, Alcaligeneceae, and Fusobacteriaceae and lower Ruminococcaceae and Lachnospiraceae) compared with controls. We found altered flora (higher Veillonellaceae), poor cognition, endotoxemia, and inflammation (IL-6, TNF-α, IL-2, and IL-13) in HE compared with cirrhotics without HE. In the cirrhosis group, Alcaligeneceae and Porphyromonadaceae were positively correlated with cognitive impairment. Fusobacteriaceae, Veillonellaceae, and Enterobacteriaceae were positively and Ruminococcaceae negatively related to inflammation. Network-analysis comparison showed robust correlations (all P < 1E-5) only in the HE group between the microbiome, cognition, and IL-23, IL-2, and IL-13. Lactulose withdrawal did not change the microbiome significantly beyond Fecalibacterium reduction. We concluded that cirrhosis, especially when complicated with HE, is associated with significant alterations in the stool microbiome compared with healthy individuals. Specific bacterial families (Alcaligeneceae, Porphyromonadaceae, Enterobacteriaceae) are strongly associated with cognition and inflammation in HE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the bacterial family Porphyromonadaceae has been linked to declines in cognition and affective disorders”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Bajaj et al., 2012
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In individuals with alcohol addiction, drinking can disrupt intestinal barrier function, also known as intestinal leakage [11, 12].”
From Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial (2023) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Nucleic acid techniques in bacterial systematics
Stackebrandt, E. S., & Goodfellow, M. (1991) · Wiley eBooks · Cited by 9,460
Lane, D. (1991) · Medical Entomology and Zoology · Cited by 8,190
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228
Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,599
Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063
Characterization of fecal microbial communities in patients with liver cirrhosis
Chen, Y., Yang, F., Lu, H., Wang, B., Chen, Y., Lei, D., Wang, Y., Zhu, B., & Li, L. (2011) · Hepatology · doi:10.1002/hep.24423 · Cited by 1,038
Microbial community profiling for human microbiome projects: Tools, techniques, and challengesPreprint
Hamady, M., & Knight, R. D. (2009) · Genome Research · doi:10.1101/gr.085464.108 · Cited by 1,031
Flagged first, then by citations
2 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 555
Intestinal permeability in a patient with liver cirrhosis
Aguirre-Valádez, J., Rivera-Espinosa, L., Méndez-Guerrero, O., Chávez-Pacheco, J. L., Juárez, I. G., & Torre, A. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s115902 · Cited by 52
Gut Microbiota Drives Metabolic Disease in Immunologically Altered Mice
Chassaing, B., Aitken, J. D., Gewirtz, A. T., & Vijay–Kumar, M. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394300-2.00003-x · Cited by 51
Mehta, R. M., Kabrawala, M. V., Nandwani, S. K., Kalra, P., Patel, C. N., Desai, P. N., & Parekh, K. K. (2018) · Indian Journal of Gastroenterology · doi:10.1007/s12664-018-0906-1 · Cited by 48
Luo, M., Xin, R., Hu, F.-R., Li, Y., Hu, S., & Bai, F. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.144 · Cited by 51
Large intestine permeability is increased in patients with compensated liver cirrhosis
Pijls, K. E., Koek, G. H., Elamin, E. E., de Vries, H., Masclee, A., & Jonkers, D. M. A. E. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00330.2013 · Cited by 47
Panasevich, M. R., Morris, E. M., Chintapalli, S. V., Wankhade, U. D., Shankar, K., Britton, S. L., Koch, L. G., Thyfault, J. P., & Rector, R. S. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00065.2016 · Cited by 47
Yang, Q., Guo, S., Lu, Q., Tao, Y., Zheng, D., Zhou, Q., & Liu, J. (2021) · Bioscience Reports · doi:10.1042/bsr20211135 · Cited by 46
Liu, F., Duan, M., Fu, H., Zhao, G., Han, Y., Lan, F., Ahmed, Z., Cao, G., Li, Z., Ma, D., et al. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005489 · Cited by 47
Suzuki, K., Endo, R., Takikawa, Y., Moriyasu, F., Aoyagi, Y., Moriwaki, H., Terai, S., Sakaida, I., Sakai, Y., Nishiguchi, S., et al. (2017) · Hepatology Research · doi:10.1111/hepr.13045 · Cited by 49
The Intestinal Microbiome and the Liver Transplant Recipient
Doycheva, I., Leise, M. D., & Watt, K. D. S. (2015) · Transplantation · doi:10.1097/tp.0000000000001008 · Cited by 45
Boeri, L., Izzo, L., Sardelli, L., Tunesi, M., Albani, D., & Giordano, C. (2019) · Bioengineering · doi:10.3390/bioengineering6040091 · Cited by 47
Naudhani, M., Thakur, K., Ni, Z., Zhang, J., & Wei, Z. (2021) · Food & Function · doi:10.1039/d1fo02942h · Cited by 44
Shen, T. D., Pyrsopoulos, N., & Rustgi, V. K. (2018) · Liver Transplantation · doi:10.1002/lt.25008 · Cited by 44
Effects of Alcohol on the Brain in Cirrhosis: Beyond Hepatic Encephalopathy
Davis, B., & Bajaj, J. S. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13605 · Cited by 44
Self-citationGut Microbiota and Microbiota-Related Metabolites as Possible Biomarkers of Cognitive Aging
Ticinesi, A., Nouvenne, A., Tana, C., Prati, B., & Meschi, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-25650-0_8 · Cited by 45
Bloom, P. P., Luévano, J. M., Miller, K. J., & Chung, R. T. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100333 · Cited by 45
Li, M., Li, K., Tang, S., Lv, Y., Wang, Q., Wang, Z., Luo, B., Niu, J., Zhu, Y., Guo, W., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100448 · Cited by 42
Impact of Gut Microbiota in Brain Ageing: Polyphenols as Beneficial Modulators
Sarubbo, F., Moranta, D., Tejada, S., Jiménez-García, M., & Esteban, S. (2023) · Antioxidants · doi:10.3390/antiox12040812 · Cited by 44
The Role of Bile Acids in the Human Body and in the Development of Diseases
Shulpekova, Y. O., Жаркова, М. С., Tkachenko, P. E., Тихонов, И. Н., Stepanov, A. A., Sinitsyna, A. A., Izotov, A., Butkova, T. V., Shulpekova, N. V., Лапина, Н. В., et al. (2022) · Molecules · doi:10.3390/molecules27113401 · Cited by 46
Gut microbiota combined with metabolomics reveal the mechanism of curcumol on liver fibrosis in mice
Zheng, Y., Wang, J., Wang, J., 姜瑞祝, Liang, T., & Zhao, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113204 · Cited by 41
Jung, J. H., Kim, S. E., Suk, K. T., & Kim, D. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913842 · Cited by 42
Wang, Q., Chen, C., Zuo, S., Cao, K., & Li, H. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04262-9 · Cited by 44
Probiotics in management of hepatic encephalopathy
Sharma, B. C., & Singh, J. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9826-x · Cited by 40
Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics
Cho, M. S., Kim, S. Y., Suk, K. T., & Kim, B. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-8346-2 · Cited by 42
Major Lipids, Apolipoproteins, and Alterations of Gut Microbiota
Yun, K. E., Kim, J., Kim, M.-H., Park, E., Kim, H., Chang, Y., Ryu, S., & Kim, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051589 · Cited by 40
Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver
Gupta, H., Suk, K. T., & Kim, D. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030541 · Cited by 43
Trust Your Gut: The Association of Gut Microbiota and Liver Disease
Manzoor, R., Ahmed, W., Afify, N., Memon, M., Yasin, M., Memon, H., Rustom, M., Akeel, M. A., & Alhajri, N. (2022) · Microorganisms · doi:10.3390/microorganisms10051045 · Cited by 40
Current approaches to hepatic encephalopathy
Vidal‐Cevallos, P., Chávez-Tapia, N. C., & Uribe, M. (2022) · Annals of Hepatology · doi:10.1016/j.aohep.2022.100757 · Cited by 39
Zhang, W., Sun, Z., Zhang, Q., Sun, Z., Su, Y., Song, J., Wang, B., & Gao, R. (2021) · BMC Pediatrics · doi:10.1186/s12887-021-02539-w · Cited by 37
Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence
Dai, W., Liu, J., Yan, Q., Teng, Z., Li, S., Yuan, H., Huang, J., Xiang, H., Tang, H., Wang, B., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.893567 · Cited by 42
Xiao, J., Li, S., Sui, Y., Wu, Q., Li, X., Xie, B., Zhang, M., & Sun, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112773 · Cited by 39
Altered Gut Microbiota in a Fragile X Syndrome Mouse Model
Altimiras, F. J., García, J., Palacios-García, I., Hurley, M. J., Deacon, R. M. J., González, B., & Cogram, P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653120 · Cited by 39
Microbiome Alterations in Alcohol Use Disorder and Alcoholic Liver Disease
Litwinowicz, K., & Gamian, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032461 · Cited by 38
Clinical and Pathophysiological Consequences of Alterations in the Microbiome in Cirrhosis
Macnaughtan, J., & Jalan, R. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.313 · Cited by 38
Clinical impact of microbiome in patients with decompensated cirrhosis
Oikonomou, T., Papatheodoridis, G., Samarkos, M., Goulis, I., & Cholongitas, Ε. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i34.3813 · Cited by 38
China, L., Skene, S. S., Bennett, K., Shabir, Z., Hamilton, R., Bevan, S., Chandler, T., Maini, A. A. N., Bécares, N., Gilroy, D. W., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023754 · Cited by 37
Moratalla, A., Ampuero, J., Bellot, P., Gallego‐Durán, R., Zapater, P., Roger, M., Figueruela, B., Martínez‐Moreno, B., González-Navajas, J. M., Such, J. M., et al. (2016) · Liver International · doi:10.1111/liv.13200 · Cited by 39
Bacterial infections and hepatic encephalopathy in liver cirrhosis–prophylaxis and treatment
Piotrowski, D., & Boroń‐Kaczmarska, A. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.11.009 · Cited by 36
Karoly, H. C., Mueller, R. L., Bidwell, L. C., & Hutchison, K. E. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14256 · Cited by 37
Lactobacillus paracasei CNCM I-5220-derived postbiotic protects from the leaky-gut
Algieri, F., Tanasković, N., Rincón, C. L. C., Notario, E., Braga, D., Pesole, G., Rusconi, R., Penna, G., & Rescigno, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1157164 · Cited by 43
Kawaguchi, T., Suzuki, F., Imamura, M., Murashima, N., Yanase, M., Mine, T., Fujisawa, M., Sato, I., Yoshiji, H., Okita, K., et al. (2018) · Hepatology Research · doi:10.1111/hepr.13300 · Cited by 36
Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification
Panasevich, M. R., Peppler, W. T., Oerther, D. B., Wright, D. C., & Rector, R. S. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00012.2017 · Cited by 35
The Human Gut Microbiome in Liver Diseases
Davis, B., & Bajaj, J. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1602763 · Cited by 34
Self-citationKhaledi, M., Poureslamfar, B., Alsaab, H. O., Tafaghodi, S., Hjazi, A. M., Singh, R., Alawadi, A. H., Alsaalamy, A. H., Qasim, Q. A., & Sameni, F. (2024) · Annals of Microbiology · doi:10.1186/s13213-023-01744-5 · Cited by 50
Toribio-Mateas, M. A. (2018) · Microorganisms · doi:10.3390/microorganisms6020035 · Cited by 37
Antipsychotics and the microbiota
Chen, A., Park, T. Y., Li, K. J., & DeLisi, L. E. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000594 · Cited by 34
Li, F., Zhao, C., Shao, T., Liu, Y., Gu, Z., Jiang, M., Li, H., Zhang, L., Gillevet, P. M., Puri, P., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5531 · Cited by 34
Self-citationNeuroimmune modulation in liver pathophysiology
Zou, J., Li, J., Wang, X., Tang, D., & Chen, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03181-w · Cited by 36
Implication of the intestinal microbiome in complications of cirrhosis
Bhat, M., Arendt, B. M., Bhat, V., Renner, E. L., Humar, A., & Allard, J. P. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i27.1128 · Cited by 36
Luo, M., Li, L., Yang, E.-N., Dai, C.-Y., Shu-ren, L., & Cao, W. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.08.007 · Cited by 33
Implication of Gut Microbiota in Human Health
Khan, I., Yasir, M., Azhar, E. I., Kumosani, T. A., Barbour, E. K., Bibi, F., & Kamal, M. A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141023153506 · Cited by 35
Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model
Huang, H., Lin, Z., Zeng, Y., Lin, X., & Zhang, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8123 · Cited by 32
Effect of IRT5 probiotics on dry eye in the experimental dry eye mouse model
Moon, J., Ryu, J. S., Kim, J. Y., Im, S., & Kim, M. K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243176 · Cited by 34
Ambient temperature alters body size and gut microbiota of Xenopus tropicalis
Li, J., Rui, J., Li, Y., Tang, N., Zhan, S., Jiang, J., & Li, X. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-9540-y · Cited by 30
Lee, J. S., O’Connell, E. M., Pacher, P., & Lohoff, F. W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081758 · Cited by 31
Diversity of the gut-microbiome related to cognitive behavioral outcomes in healthy older adults
Canipe, L. G., Sioda, M., & Cheatham, C. L. (2021) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2021.104464 · Cited by 31
Effects of Konjaku Flour on the Gut Microbiota of Obese Patients
Li, Y., Kang, Y., Du, Y., Chen, M., Guo, L., Huang, X., Li, T., Chen, S., Yang, F., Yu, F., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.771748 · Cited by 33
Манжалій, Е., Moyseyenko, V. O., Кondratiuk, V. Y., Molochek, N., Falalyeyeva, T. M., & Kobyliak, N. M. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i3.634 · Cited by 31
Gut Microbiota, Inflammation and Hepatic Encephalopathy: A Puzzle with a Solution in Sight
Dhiman, R. K. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2012.08.004 · Cited by 31
Altered gut microbiome promotes proteinuria in mice induced by Adriamycin
Jiang, Q., He, X., Zou, Y., Ding, Y., Li, H., & Chen, H. (2018) · AMB Express · doi:10.1186/s13568-018-0558-7 · Cited by 31
The gut microbiota and the liver: implications for clinical practice
Quigley, E. M. M., & Monsour, H. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2013.848167 · Cited by 30
Jain, V., Alexander, E. C., Burford, C., Verma, A., & Dhawan, A. K. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002973 · Cited by 31
Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives
Rocco, A., Sgamato, C., Compare, D., Coccoli, P., Nardone, O. M., & Nardone, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748253 · Cited by 32
Cao, X., Zolnikova, O. Y., Maslennikov, R. V., Reshetova, M. S., Poluektova, E. A., Bogacheva, A., Жаркова, М. С., & Ivashkin, V. T. (2023) · Metabolites · doi:10.3390/metabo13070859 · Cited by 29
Vázquez‐Cuesta, S., Lozano-García, N., Fernández, S. R., Fernández, A. I., Bermejo, J., Fernández‐Avilés, F., Muñóz, P., Bouza, E., & Reigadas, E. (2024) · Nutrients · doi:10.3390/nu16060793 · Cited by 29
Lamas‐Paz, A., Morán, L., Peng, J., Salinas, B., López‐Alcántara, N., Sydor, S., Vilchez‐Vargas, R., Asensio, I., Hao, F., Zheng, K., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.603771 · Cited by 27
Iqbal, U., Jadeja, R. N., Khara, H. S., & Khurana, S. (2021) · Nutrients · doi:10.3390/nu13020370 · Cited by 31
Towards multi-label classification: Next step of machine learning for microbiome research
Wu, S., Chen, Y., Li, Z., Li, J., Zhao, F., & Su, X. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.054 · Cited by 29
The Role of the Microbiome in Liver Cancer
Moreno‐Gonzalez, M., & Beraza, N. (2021) · Cancers · doi:10.3390/cancers13102330 · Cited by 29
Shah, Y. R., Ali, H., Tiwari, A., Guevara-Lazo, D., Nombera-Aznaran, N., Pinnam, B. S. M., Gangwani, M. K., Gopakumar, H., Sohail, A. H., Kanumilli, S., et al. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i1.17 · Cited by 30
Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
Bellafante, D., Gioia, S., Faccioli, J., Riggio, O., Ridola, L., & Nardelli, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031187 · Cited by 28
Alcohol and its associated liver carcinogenesis
Jacob, R., Prince, D. S., Kench, C., & Liu, K. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16248 · Cited by 29
Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
Hatton, G. B., & Shawcross, D. L. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1543587 · Cited by 28
Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease
Giuli, L., Maestri, M., Santopaolo, F., Pompili, M., & Ponziani, F. R. (2023) · Metabolites · doi:10.3390/metabo13060772 · Cited by 30
New Insights into Stroke Prevention and Treatment: Gut Microbiome
Zhao, L., Yang, L., Guo, Y., Xiao, J., Zhang, J., & Xu, S. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01047-w · Cited by 29
Li, Y., Yu, Z., Li, A., & Ren, Z. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i28.3555 · Cited by 28
Hepatic encephalopathy – recent advances in treatment and diagnosis
Nardelli, S., Gioia, S., Faccioli, J., Riggio, O., & Ridola, L. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2183386 · Cited by 27
Kelly, D. L., Lyon, D., Yoon, S. L., & Horgas, A. L. (2015) · Cancer Nursing · doi:10.1097/ncc.0000000000000286 · Cited by 28
Clinical science workshop: targeting the gut-liver-brain axis
Patel, V., White, H., Støy, S. H., Bajaj, J. S., & Shawcross, D. L. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9743-4 · Cited by 28
Self-citationKim, A. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000356 · Cited by 29
Huang, X., Fang, S., Yang, H., Gao, J., He, M., Ke, S., Zhao, Y., Chen, C., & Huang, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-15044-x · Cited by 29
Sanborn, V. E., Azcárate-Peril, M. A., Updegraff, J. A., Manderino, L. M., & Gunstad, J. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.11.006 · Cited by 27
Lipták, R., Gromová, B., & Gardlík, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.665520 · Cited by 26
Wang, M., Ma, W., Wang, Y., Ma, X., Xue, Y.-F., Guan, J. Z., & Chen, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1091167 · Cited by 26
Stadlbauer, V., Komarova, I., Klymiuk, I., Durdević, M., Reisinger, A. C., Blesl, A., Rainer, F., & Horvath, A. (2020) · Liver International · doi:10.1111/liv.14382 · Cited by 27
Liu, J., Xu, Y., & Jiang, B. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.586427 · Cited by 25
Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review
Gu, X., Lu, Q., Zhang, C., Tang, Z., & Chu, L. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1732319 · Cited by 26
Gut Microbiota and Its Role in Anti-aging Phenomenon: Evidence-Based Review
Li, R., & Roy, R. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04423-y · Cited by 26
Gairing, S. J., Schleicher, E. M., Galle, P. R., & Labenz, C. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000096 · Cited by 26
Infection, inflammation and hepatic encephalopathy from a clinical perspective
Ntuli, Y., & Shawcross, D. L. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01402-y · Cited by 31
Allegri, G., Deplazes, S., Rimann, N., Causton, B., Scherer, T., Leff, J. W., Díez‐Fernández, C., Klimovskaia, A., Fingerhut, R., Krijt, J., et al. (2019) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12068 · Cited by 24
A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
Petrella, C., Vecchioli, S. F., Cisale, G. Y., Strimpakos, G., Borg, J.-J., Ceccanti, M., Fiore, M., Monteleone, G., & Nisticò, R. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200730111528 · Cited by 24
The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure
Kim, S. E., Park, J. W., Kim, H. S., Jang, M. K., Suk, K. T., & Kim, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111680 · Cited by 24
Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease
Račkayová, V., Flatt, E., Braissant, O., Grosse, J., Capobianco, D., Mastromarino, P., McMillin, M., DeMorrow, S., McLin, V. A., & Cudalbu, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-81871-8 · Cited by 24
Hines, I. S., Ferguson, C. S., Bushman, T. J., Gatlin, D. M., Jensen, R. V., Smith, S. A., Kuhn, D. D., & Stevens, A. M. (2020) · Aquaculture Research · doi:10.1111/are.15011 · Cited by 23
Self-citationThe shaping of gut immunity in cirrhosis
Muñoz, L., Caparrós, E., Albillos, A., & Francés, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139554 · Cited by 24
Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain
Shahbazi, A., Sepehrinezhad, A., Vahdani, E., Jamali, R., Ghasempour, M., Massoudian, S., Negah, S. S., & Larsen, F. S. (2023) · Biomedicines · doi:10.3390/biomedicines11051272 · Cited by 25
Wu, Y., Dong, Z.-Y., Jiang, X., Qu, L., Zhou, W., Sun, X., Hou, J., Xu, H., & Cheng, M. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00302-23 · Cited by 24
Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy.
Shavakhi, A., Hashemi, H., Tabesh, E., Derakhshan, Z., Farzamnia, S., Meshkinfar, S., Shavakhi, S., Minakari, M., & Gholamrezaei, A. (2014) · Europe PMC (PubMed Central) · Cited by 23
The Gut Microbiota, Tumorigenesis, and Liver Diseases
Lv, G., Cheng, N., & Wang, H. (2017) · Engineering · doi:10.1016/j.eng.2017.01.017 · Cited by 24
Metadata
- Authors
- Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., Sikaroodi, M., & Gillevet, P. M.
- Affiliations
- Divisions of 1Gastroenterology, Hepatology and Nutrition,
- Virginia Commonwealth University (US)
- George Mason University (US)
- Corresponding author
- Bajaj, Jasmohan S.
- ORCID
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2012-01
- Volume
- 302
- Issue
- 1
- Pages
- G168-G175
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- PMC
- PMC3345956
- OpenAlex
- W2058029859
- Cited by
- 547
- References
- 49
- Citations by year
- 2026: 10 · 2025: 30 · 2024: 43 · 2023: 60 · 2022: 40 · 2021: 45 · 2020: 42 · 2019: 49 · 2018: 43 · 2017: 36 · 2016: 34 · 2015: 32 · 2014: 33 · 2013: 25 · 2012: 23
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Physiology-Gastrointestinal and Liver Physiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American College of Gastroenterology
- Virginia Commonwealth University
- National Institute on Alcohol Abuse and Alcoholism (R01AA020203)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK087913)
- National Center for Complementary and Alternative Medicine
- National Center for Complementary and Integrative Health (U01AT004428)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- hepatic encephalopathy, gut microbiota, cognitive impairment, liver cirrhosis, inflammation, endotoxemia, rifaximin, Veillonellaceae, Enterobacteriaceae, Alcaligenaceae, Porphyromonadaceae, inflammatory cytokines, intestinal barrier dysfunction, systems biology
- MeSH terms
- Rifaximin, Cognition Disorders, Endotoxins, Feces, Female, Gastrointestinal Agents, Hepatic Encephalopathy, Humans, Lactulose, Liver Cirrhosis, Male, Middle Aged, Rifamycins, Cytokines, Gastrointestinal Tract, Systems Biology, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
